Proton therapy and the European Particle Therapy Network: The past, present and futureWeber, D. C., Langendijk, J. A., Grau, C. & Thariat, J., Oct-2020, In : Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 24, 6-7, p. 687-690 4 p.
Research output: Contribution to journal › Article › Academic › peer-review
Proton therapy is delivered to selected cancer patients presenting with rare tumours, for which a dose escalation paradigm and/or a reduced dose-bath to the organs at risk is pursued. It is a costly treatment with an additional cost factor of 2-3 when compared to photon radiotherapy. Notwithstanding the 180'000 patients treated with protons, scars robust clinical evidence is available to justify the administration of this treatment modality. The European Particle Therapy Network (EPTN) was created in 2015 to answer the critical European needs for cooperation among protons and carbon ions centres in the framework of clinical research networks. EPTN with other European groups will launch a number of prospective clinical trials that could be practice changing if positive. Alternative way to generate clinical data could be provided by alternative methodologies, such as the Dutch model-based approach, or could be provided by European infrastructure projects. (C) 2020 Societe francaise de radiotherapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.
|Number of pages||4|
|Journal||Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique|
|Early online date||1-Aug-2020|
|Publication status||Published - Oct-2020|
|Event||Meeting of the Societe-Francaise-de-Radiotherapie-Oncologique (SFRO) - Paris, France|
Duration: 8-Oct-2020 → …
Meeting of the Societe-Francaise-de-Radiotherapie-Oncologique (SFRO)
08/10/2020 → …Paris, France
- Proton therapy, EPTN, European research networks, Cancer, European research infrastructure, COST-EFFECTIVENESS, CLINICAL-TRIALS, RADIATION, REDUCTION